Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer-Reference-Cited by-同舟云学术

Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer

Published:2022-07-21 Issue:14 Volume:14 Page:3539
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Coveñas Rafael^ORCID,Muñoz Miguel^ORCID

Abstract

New, promising molecular targets to block tumor development and new compounds capable of specifically destroying cancer cells must be urgently investigated [...]

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/14/14/3539/pdf

Reference22 articles.

1. The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia

2. SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant

3. Neurokinin receptor antagonism: a patent review (2014-present)

4. The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors

5. Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the peripheral neural-tumour microenvironment for cancer therapy;Nature Reviews Drug Discovery;2024-09-06

2. Glioma and Peptidergic Systems: Oncogenic and Anticancer Peptides;International Journal of Molecular Sciences;2024-07-22

3. Antitumor Strategies Targeting Peptidergic Systems;Encyclopedia;2024-03-06

4. Fighting Cancer Using Selective Antagonists Targeting the Substance P/Neurokinin-1 Receptor System;Interdisciplinary Cancer Research;2024

5. Role of Neuropeptides in Sarcomas;Neurochemical Journal;2023-12